Evidence map›Paper›PMID 17599958›Full record

ArticleClinical chemistry2007

Oxidative stress markers are associated with persistent atrial fibrillation.

Robert B Neuman, Heather L Bloom, Irfan Shukrullah, Lyndsey A Darrow, David Kleinbaum, Dean P Jones, Samuel C Dudley

2 registry-linked trialsOpen access · bronzeAbstract read
In one paragraph

Article in Clinical chemistry, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 110 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
110citing papers in PubMed, 3 pooled it
9.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00142194 completednot on this map

Markers of Oxidative Stress Present in Blood in Patients With Atrial Fibrillation

TypeobservationalSponsorEmory UniversityRan2005 to 2007Enrolled47ConditionsAtrial Fibrillation, Inflammation, Atrial Flutter
NCT02502110 phase4unknown statusnot on this mapstarted 2015, after this paper: background citation

The Study of Rosuvastatin for Reduction of Postoperative Paroxysmal Atrial Fibrillation in Patient Undergoing Radiofrequency Catheter Ablation

TypeinterventionalSponsorThe Third Xiangya Hospital of Central South UniversityRan2015 to 2019Enrolled346ConditionsParoxysmal Atrial FibrillationArmsrosuvastatin
3 · Its place in the literature

Who cites it

110 citing papers in PubMed, 3 syntheses or guidelines pooled it, 220 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Review
  10. Article
  11. Review
  12. Pathogenesis of Oxidative Stress Biomarkers in Atrial Fibrillation: A Narrative Review.The Journal of innovations in cardiac rhythm management · 2026
    Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Atrial fibrillation, hypertension, and the cerebral vasodilatory reserve.Hypertension research : official journal of the Japanese Society of Hypertension · 2024
    Article
  18. Article
  19. Article
  20. The effect of hypertension on cerebrovascular carbon dioxide reactivity in atrial fibrillation patients.Hypertension research : official journal of the Japanese Society of Hypertension · 2024
    Article

50 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Robert B NeumanDivision of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
Heather L Bloom
Irfan Shukrullah
Lyndsey A Darrow
David Kleinbaum
Dean P Jones
Samuel C Dudley
Emory University · USVeterans Health Administration · US

Funding

REGULATION OF VASCULAR FUNCTION BY THE ENDOTHELIUMR01HL039006 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HARRISON, DAVID G · 1987 to 2017
$5.5M
Genetic Modulators of Sudden DeathR01HL077398 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LONDON, BARRY · 2004 to 2008
$2.6M
Angiotensin converting enzyme, angiotensin II, and arrhythmiaR01HL085558 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI DUDLEY, SAMUEL C · 2007 to 2010
$1.5M
Stem Cell Therapy and ArrhythmiaR01HL073753 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI DUDLEY, SAMUEL C · 2005 to 2008
$1.4M
NHLBI NIH HHS HL39006NHLBI NIH HHS HL73753NHLBI NIH HHS HL77398NHLBI NIH HHS R01 HL039006NHLBI NIH HHS R01 HL073753NHLBI NIH HHS R01 HL077398NHLBI NIH HHS R01 HL085558
6 · The paper itself

Abstract

backgroundAtrial fibrillation (AF) has been associated with myocardial oxidative stress, and antioxidant agents have demonstrated antiarrhythmic benefit in humans. We compared serum markers of oxidation and associated inflammation in individuals with or without AF.

methodsSerum markers of oxidative stress and inflammation were compared in a cross-sectional, case-control design study of 40 male individuals, with or without persistent or permanent AF, who were matched for age, sex, diabetes, and smoking status, known confounding variables for the measurement of oxidative stress. We used derivatives of reactive oxidative metabolites (DROMs) and ratios of oxidized to reduced glutathione (E(h) GSH) and cysteine (E(h) CySH) to quantify oxidative stress. We also measured inflammatory markers, including high-sensitivity C-reactive protein, interleukins 1beta and 6, and tumor necrosis factor alpha.

resultsUnivariate, conditional logistical regression analysis showed that oxidative stress but not inflammatory markers were statistically associated with AF (P <0.05). The increase in the odds ratios for AF for E(h) GSH, E(h) CySH, and DROMs were 6.1 (95% CI, 1.3-28.3; P = 0.02), 13.6 (95% CI, 2.5-74.1; P = 0.01), and 15.9 (95% CI, 1.7-153.9; P = 0.02), respectively. There was a stronger correlation between E(h) GSH and E(h) CySH (r = 0.66) than between E(h) GSH and DROMs (r = 0.41). In multivariate analysis corrected for statins and other AF risk factors differing between the groups, the association of AF and oxidative stress remained significant.

conclusionsThese data suggest that oxidative stress markers may have predictive value in AF management.

Indexed as

Oxidative StressAgedAged, 80 and overAtrial FibrillationBiomarkersCase-Control StudiesC-Reactive ProteinCross-Sectional StudiesCysteineDiabetes Mellitus, Type 2GlutathioneHumansInflammationInterleukin-1betaInterleukin-6MaleBiomarkersC-Reactive ProteinCysteineGlutathioneInterleukin-1betaInterleukin-6Tumor Necrosis Factor-alpha

Identifiers

PMID17599958
PMCPMC3158654
OpenAlexW2023263797

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.